Item Type | Name |
Academic Article
|
Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production.
|
Academic Article
|
Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist.
|
Academic Article
|
Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist.
|
Academic Article
|
Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes--evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood.
|
Academic Article
|
Interleukin-1 receptor antagonist suppresses contact hypersensitivity.
|
Academic Article
|
Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
|
Academic Article
|
Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts.
|
Academic Article
|
Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts.
|
Academic Article
|
Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.
|
Academic Article
|
Blocking interleukin-1 receptors.
|
Academic Article
|
Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
|
Academic Article
|
Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.
|
Academic Article
|
Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones.
|
Academic Article
|
Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
|
Academic Article
|
Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis.
|
Academic Article
|
Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.
|
Academic Article
|
Interleukin-1.
|
Academic Article
|
Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.
|
Academic Article
|
Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.
|
Academic Article
|
Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
|
Academic Article
|
Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion.
|
Academic Article
|
Modalities for reducing interleukin 1 activity in disease.
|
Academic Article
|
Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist.
|
Academic Article
|
Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.
|
Academic Article
|
Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
|
Academic Article
|
Intestinal production of interleukin-1 alpha during endotoxemia in the mouse.
|
Academic Article
|
The role of interleukin-1 in host responses to infectious diseases.
|
Academic Article
|
The role of interleukin-1 in disease.
|
Academic Article
|
Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
|
Academic Article
|
Induction of circulating IL-1 receptor antagonist by IFN treatment.
|
Academic Article
|
Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
|
Academic Article
|
Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein.
|
Academic Article
|
Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
|
Academic Article
|
Bacterial lipopolysaccharide induction of IL-6 in rat telencephalic cells is mediated in part by IL-1.
|
Academic Article
|
The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.
|
Academic Article
|
Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells.
|
Academic Article
|
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.
|
Academic Article
|
Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
|
Academic Article
|
Cytokines as mediators in the pathogenesis of septic shock.
|
Academic Article
|
Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.
|
Academic Article
|
Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism.
|
Academic Article
|
Interleukin-1 and interleukin-1 receptor antagonist.
|
Academic Article
|
Three distinct promoters direct transcription of different 5' untranslated regions of the human interleukin 1 type I receptor: a possible mechanism for control of translation.
|
Academic Article
|
Glycosylation of the interleukin-1 receptor type I is required for optimal binding of interleukin-1.
|
Academic Article
|
The natural interleukin-1 receptor antagonist in term and preterm parturition.
|
Academic Article
|
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans.
|
Academic Article
|
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.
|
Academic Article
|
Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
|
Academic Article
|
Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells.
|
Academic Article
|
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
|
Academic Article
|
Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra).
|
Academic Article
|
The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.
|
Academic Article
|
[Antagonists in neonatal sepsis].
|
Academic Article
|
The biological properties of interleukin-1.
|
Academic Article
|
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.
|
Academic Article
|
Leptin deficiency enhances sensitivity to endotoxin-induced lethality.
|
Academic Article
|
Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist.
|
Academic Article
|
Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
|
Academic Article
|
Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.
|
Academic Article
|
Dissociation of transcription from translation of human IL-1 beta: induction of steady state mRNA by adherence or recombinant C5a in the absence of translation.
|
Academic Article
|
Monokine antagonism is reduced in patients with IDDM.
|
Academic Article
|
Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.
|
Academic Article
|
Interleukin-18.
|
Academic Article
|
The biology of interleukin-1.
|
Academic Article
|
Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
|
Academic Article
|
Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus.
|
Academic Article
|
Blocking interleukin-1 in disease.
|
Academic Article
|
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.
|
Academic Article
|
Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.
|
Academic Article
|
Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.
|
Academic Article
|
Is there an interleukin-1 genetic predisposition to developing severe sepsis?
|
Academic Article
|
Modalities for reducing interleukin 1 activity in disease.
|
Academic Article
|
IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor.
|
Academic Article
|
Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia.
|
Academic Article
|
Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event.
|
Academic Article
|
The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense.
|
Academic Article
|
Biologic basis for interleukin-1 in disease.
|
Academic Article
|
Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain.
|
Academic Article
|
Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity.
|
Academic Article
|
The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.
|
Academic Article
|
Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
|
Academic Article
|
Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.
|
Academic Article
|
Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.
|
Academic Article
|
Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.
|
Academic Article
|
An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
|
Academic Article
|
Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice.
|
Academic Article
|
IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia.
|
Academic Article
|
The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
|
Academic Article
|
Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants.
|
Academic Article
|
Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
|
Academic Article
|
Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
|
Academic Article
|
A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
|
Academic Article
|
Setting the cytokine trap for autoimmunity.
|
Academic Article
|
Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel.
|
Academic Article
|
Enhancement of growth of virulent strains of Escherichia coli by interleukin-1.
|
Academic Article
|
Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.
|
Academic Article
|
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development.
|
Academic Article
|
Interleukin 4 (IL) 4 up-regulates gene and surface IL 1 receptor type I in murine T helper type 2 cells.
|
Academic Article
|
Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex.
|
Academic Article
|
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.
|
Academic Article
|
Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness.
|
Academic Article
|
Interleukin-1 and interleukin-1 antagonism.
|
Academic Article
|
The IL-1 family and inflammatory diseases.
|
Academic Article
|
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
|
Academic Article
|
The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
|
Academic Article
|
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.
|
Academic Article
|
Blocking IL-1 in systemic inflammation.
|
Academic Article
|
Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
|
Academic Article
|
IL-32, a novel cytokine with a possible role in disease.
|
Academic Article
|
Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.
|
Academic Article
|
Differential effects of anti-IL-1R accessory protein antibodies on IL-1alpha or IL-1beta-induced production of PGE(2) and IL-6 from 3T3-L1 cells.
|
Academic Article
|
Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
|
Academic Article
|
Resistant Beh?et disease responsive to anakinra.
|
Academic Article
|
Targeting the pathogenic role of interleukin 1{beta} in the progression of smoldering/indolent myeloma to active disease.
|
Academic Article
|
Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood.
|
Academic Article
|
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation.
|
Academic Article
|
Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling.
|
Academic Article
|
Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta.
|
Academic Article
|
Interleukin-1 and its receptor.
|
Academic Article
|
Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction.
|
Academic Article
|
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
|
Academic Article
|
Anakinra for the inflammatory complications of chronic granulomatous disease.
|
Academic Article
|
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.
|
Academic Article
|
Production of interleukin-1-receptor antagonist during experimental endotoxaemia.
|
Academic Article
|
Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1a.
|
Academic Article
|
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist.
|
Academic Article
|
Interleukin-1 and inhibition of interleukin-1 in hemodialysis patients.
|
Academic Article
|
The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses.
|
Academic Article
|
IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor.
|
Academic Article
|
Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.
|
Academic Article
|
Reduced mitogen stimulation of DNA synthesis in human lymphocytes by a human recombinant interleukin-1 receptor antagonist.
|
Academic Article
|
Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.
|
Academic Article
|
Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.
|
Academic Article
|
Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications?
|
Academic Article
|
Is there a role for interleukin-1 blockade in intravenous immunoglobulin therapy?
|
Academic Article
|
Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production.
|
Academic Article
|
Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia.
|
Academic Article
|
Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism.
|
Academic Article
|
Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone.
|
Academic Article
|
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.
|
Academic Article
|
The interleukin-1 family: 10 years of discovery.
|
Academic Article
|
Interleukin-1 receptor type I mRNA in mouse brain as affected by peripheral administration of bacterial lipopolysaccharide.
|
Academic Article
|
Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.
|
Academic Article
|
Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist.
|
Academic Article
|
Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells.
|
Academic Article
|
Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.
|
Academic Article
|
Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression.
|
Academic Article
|
Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). The Danish Study Group of Diabetes in Childhood.
|
Academic Article
|
High cytokine levels at admission are associated with fatal outcome in patients with necrotizing fasciitis.
|
Academic Article
|
Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress.
|
Academic Article
|
Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell.
|
Academic Article
|
Induction of interleukin-1 and interleukin-1 receptor antagonist.
|
Academic Article
|
Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation.
|
Academic Article
|
Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice.
|
Academic Article
|
The many worlds of reducing interleukin-1.
|
Academic Article
|
Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
|
Academic Article
|
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood.
|
Academic Article
|
Monocyte cytokine production in an elderly population: effect of age and inflammation.
|
Academic Article
|
In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD.
|
Academic Article
|
Interleukin-1.
|
Academic Article
|
Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
|
Academic Article
|
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8.
|
Academic Article
|
Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells.
|
Academic Article
|
Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
|
Academic Article
|
Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression.
|
Academic Article
|
Modulatory in vitro effects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1 beta converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth.
|
Academic Article
|
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
|
Academic Article
|
Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
|
Academic Article
|
Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia.
|
Academic Article
|
Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure.
|
Academic Article
|
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
|
Academic Article
|
Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha.
|
Academic Article
|
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.
|
Academic Article
|
Interleukin-1beta.
|
Academic Article
|
Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor.
|
Academic Article
|
Interleukin 1 receptors and biological responses.
|
Academic Article
|
Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
|
Academic Article
|
Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model.
|
Academic Article
|
Interleukin-18 and the pathogenesis of inflammatory diseases.
|
Academic Article
|
IL-18 in autoimmunity: review.
|
Academic Article
|
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.
|
Academic Article
|
Interleukin-1 and its biologically related cytokines.
|
Academic Article
|
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
|
Academic Article
|
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease.
|
Academic Article
|
Interleukin-1 induced T-lymphocyte proliferation and its relation to IL-1 receptors.
|
Academic Article
|
Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1a, IL-1? or IL-1 receptor type I.
|
Academic Article
|
Immunological and inflammatory functions of the interleukin-1 family.
|
Academic Article
|
Interleukin-1beta and the autoinflammatory diseases.
|
Academic Article
|
Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse.
|
Academic Article
|
Why not treat human cancer with interleukin-1 blockade?
|
Academic Article
|
The interleukin 1 receptor.
|
Academic Article
|
Studies on IL-1 receptors on D10S T-helper cells: demonstration of two molecularly and antigenically distinct IL-1 binding proteins.
|
Academic Article
|
Differential effects of interleukin-1 alpha and interleukin-1 beta on human peripheral blood eosinophils.
|
Academic Article
|
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.
|
Academic Article
|
Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat).
|
Academic Article
|
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
|
Academic Article
|
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].
|
Academic Article
|
Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure.
|
Academic Article
|
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
|
Concept
|
Interleukin-1 Receptor Accessory Protein
|
Concept
|
Interleukin-18 Receptor alpha Subunit
|
Concept
|
Interleukin 1 Receptor Antagonist Protein
|
Concept
|
Receptors, Interleukin-1
|
Concept
|
Receptors, Interleukin-4
|
Concept
|
Receptors, Interleukin-13
|
Concept
|
Receptors, Interleukin-2
|
Concept
|
Receptors, Interleukin-6
|
Concept
|
Receptors, Interleukin-1 Type I
|
Concept
|
Receptors, Interleukin
|
Concept
|
Receptors, Interleukin-18
|
Concept
|
Receptors, Interleukin-1 Type II
|
Concept
|
Interleukin-13 Receptor alpha1 Subunit
|
Concept
|
Receptors, Interleukin-9
|
Academic Article
|
Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).
|
Academic Article
|
The interleukin-1 family: back to the future.
|
Academic Article
|
Treating inflammation by blocking interleukin-1 in humans.
|
Academic Article
|
Interleukin-37.
|
Academic Article
|
Overview of the interleukin-1 family of ligands and receptors.
|
Academic Article
|
Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?
|
Academic Article
|
Interleukin-10 in patients with ST-segment elevation myocardial infarction.
|
Academic Article
|
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.
|
Academic Article
|
IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
|
Academic Article
|
A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist.
|
Academic Article
|
Deficient autophagy unravels the ROS paradox in chronic granulomatous disease.
|
Academic Article
|
IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis.
|
Academic Article
|
Clinical predictors of response to anakinra in patients with heart failure.
|
Academic Article
|
Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra.
|
Academic Article
|
Interleukin-1 in disease.
|
Academic Article
|
IL-2 receptor gene activation by ATL-derived factor (ADF).
|
Academic Article
|
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
|
Academic Article
|
An anti-inflammatory property of Candida albicans ?-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
|
Academic Article
|
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies).
|
Academic Article
|
Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
|
Academic Article
|
Treating pulmonary silicosis by blocking interleukin 1.
|
Academic Article
|
IL-37 requires the receptors IL-18Ra and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
|
Academic Article
|
Anakinra treatment in drug-resistant Behcet's disease: a case series.
|
Academic Article
|
Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade.
|
Academic Article
|
IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
|
Academic Article
|
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra.
|
Academic Article
|
IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
|
Academic Article
|
Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.
|
Academic Article
|
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
|
Academic Article
|
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.
|
Academic Article
|
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.
|
Academic Article
|
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.
|
Academic Article
|
Suppression of innate inflammation and immunity by interleukin-37.
|
Academic Article
|
Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1? and by the induction of endogenous IL-1Ra.
|
Academic Article
|
Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma.
|
Academic Article
|
Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.
|
Academic Article
|
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
|
Academic Article
|
Treating Life-Threatening Myocarditis by Blocking Interleukin-1.
|
Academic Article
|
Novel strategies for targeting innate immune responses to influenza.
|
Academic Article
|
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.
|
Academic Article
|
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure.
|
Academic Article
|
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance.
|
Academic Article
|
Cytokine Inhibition in Patients With Chronic Fatigue Syndrome: A Randomized Trial.
|
Academic Article
|
Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
|
Grant
|
Pathogenesis of Fever in Man
|
Academic Article
|
Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.
|
Academic Article
|
Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity.
|
Academic Article
|
Overview of the IL-1 family in innate inflammation and acquired immunity.
|
Academic Article
|
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue.
|
Academic Article
|
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition.
|
Academic Article
|
TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization.
|
Academic Article
|
An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors.
|
Academic Article
|
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
|
Academic Article
|
Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1a antibody, in a phase III randomized study of advanced colorectal cancer.
|
Academic Article
|
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis.
|
Academic Article
|
IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease.
|
Academic Article
|
The IL-1 family of cytokines and receptors in rheumatic diseases.
|
Academic Article
|
PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
|
Academic Article
|
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
|
Academic Article
|
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
|
Academic Article
|
Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects.
|
Academic Article
|
IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
|
Academic Article
|
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds.
|
Academic Article
|
Interleukin 1a: a comprehensive review on the role of IL-1a in the pathogenesis and treatment of autoimmune and inflammatory diseases.
|
Academic Article
|
A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.
|
Academic Article
|
Interleukin-1 Receptor Antagonism Abrogates Acute Pressure Overload-Induced Murine Heart Failure.
|
Academic Article
|
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy.
|
Academic Article
|
Interleukin-38 in Health and Disease.
|
Academic Article
|
Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3.
|